MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

December 08, 2014

This article was originally published in The Wall Street Journal.

December 03, 2014

NEW YORK—A United States government program meant to reward pharmaceutical companies for investing in research and development (R&D) for neglected diseases, and which will soon include Ebola on its list of eligible diseases, is enriching drug companies without ensuring that patients, treatment providers, or governments have access to these lifesaving drugs at an affordable price, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Monday.

November 18, 2014

“The pharmaceutical industry-supported Tufts Center for the Study of Drug Development claims it costs US$2.56 billion to develop a new drug today; but if you believe that, you probably also believe the earth is flat.

“GlaxoSmithKline’s CEO Andrew Witty himself says the figure of a billion dollars to develop a drug is a myth; this is used by the industry to justify exorbitant prices. We need to ask ourselves, if the CEO of a top pharmaceutical company says it’s a myth that it costs a billion dollars to develop a drug, can we really take this new figure 2.56 billion seriously?

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

September 03, 2014

In a late-breaking, two-part special, FRONTLINE investigates two of the biggest stories out of Africa in recent months: the largest Ebola outbreak on record, and Nigeria’s fight against Boko Haram—the Islamist militant group that kidnapped nearly 300 schoolgirls in April. 

August 12, 2014

NEW YORK, AUGUST 12, 2014  — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched "The Reach of War," a multimedia documentary feature exploring a single day in the life of the ongoing conflict in Syria, through the perspective of medical workers, patients, and refugees.

July 29, 2014

Kate Elder is MSF Access Campaign Vaccines Policy Advisor.

July 29, 2014

No. The Gates Foundation and MSF share many common objectives in working to address urgent global health needs in developing countries, and to ensure that appropriate vaccines, drugs, diagnostics, and other lifesaving interventions are developed and delivered to populations in need.

Pages